MODULATION OF TCR /CD3 SIGNAL TRANSDUCTION BY C-AMP /PROTEIN KINASE A
C-AMP /蛋白激酶 A 对 TCR /CD3 信号转导的调节
基本信息
- 批准号:3804897
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:CD3 molecule T cell receptor T lymphocyte adenylate cyclase biological signal transduction cyclic AMP enzyme induction /repression enzyme inhibitors enzyme mechanism forskolin guanosine triphosphate hydrolysis inositol isozymes leukocyte activation /transformation lymphocyte proliferation lymphokines membrane proteins nucleotide analog phospholipase C phospholipids phosphorylation prostaglandin E protein kinase secretion transport proteins
项目摘要
To study the mechanism of activation of the hydrolysis of inositol
phospholipids (InsPL) in response to perturbation of the murine T
lymphocyte Ag receptor (TCR/CD3), and its regulation by activators of
the adenylate cyclase (AC) system. The hydrolysis of InsPL, one of the
most rapid responses observed in T cells, is deemed to have a role as a
transducer of the signal initiated at the TCR/CD3. This metabolic
pathway is centered on the activation of an enzyme, an InsPL-specific
phospholipase C (PLC). A second signal transduction mechanism of
relevance in T lymphocyte activation is represented by the AC/cAMP
pathway. AC activation in Th cells has been clearly documented in
response to either pharmacological treatment (i.e. FSK, CTx) of
lymphocytes or to autocoids (i.e.: prostaglandin E2). Increased levels
of cAMP are associated with down regulation of several T cell responses,
including lymphokine secretion and proliferation. The mechanism by
which increased levels of cAMP depress lymphocyte function is not
defined, but our preliminary data indicates that it is associated with
a decrease in InsPL hydrolysis. We propose to investigate the effect of
AC activators and cAMP on the regulation of InsPL hydrolysis in response
to TCR/CD3 perturbation in intact or permeabilized cells. This approach
will allow us to characterize the site of action of cAMP in inhibiting
TCR/CD3-mediated InsPL hydrolysis. We have been able to induce InsPL
hydrolysis in permeabilized T cells by the addition of non-hydrolyzable
analogs of GTP (such as GTPgammaS), which are otherwise non-permeable to
intact cells. GTPgammaS activates a G-protein that regulates PLC
activity, thus bypassing the TCR/CD3 (or other cell surface structure).
Activation of the cAMP/PKA pathway results in inhibition of InsPL
hydrolysis triggered via TCR/CD3 perturbation, but does not affect
GTPgammaS-induced PLC activation. Therefore the two pathways may be
distinct. Although cAMP-mediated inhibition does not occur after
permeabilization, addition of purified PKA reconstituted the inhibitory
effect, which was associated with a specific pattern of phosphorylation
of membrane proteins, and included a PLC isozyme, PLC-gamma1. Attempts
will be made to understand the functional relationship between PLC-
gamma1 phosphorylation by PKA and CD3-mediated activation.
肌醇水解酶的活化机理研究
磷脂(InsPL)对小鼠T细胞扰动的反应
淋巴细胞抗原受体(TCR/CD3)及其激活剂的调节
腺苷环化酶(AC)系统。InsPL的水解是一种
在T细胞中观察到的大多数快速反应被认为具有
在TCR/CD3启动的信号传感器。这种新陈代谢
途径以一种酶的激活为中心,这种酶是InsPL特有的
磷脂酶C(PLC)。第二种信号转导机制
AC/cAMP与T淋巴细胞活化的相关性
路径。Th细胞中AC的激活已清楚地记录在
对药物治疗(如FSK、CTX)的反应
淋巴细胞或自体激素(如:前列腺素E_2)。增加的级别
CAMP的表达与几种T细胞反应的下调有关,
包括淋巴因子的分泌和增殖。这个机制是通过
CAMP水平升高抑制淋巴细胞功能不是
已定义,但我们的初步数据表明它与
InsPL水解率降低。我们建议调查一下
AC激活剂和cAMP对InsPL水解酶的调节作用
对完整或通透性细胞中TCR/CD3的扰动。这种方法
将使我们能够确定cAMP抑制的作用部位
TCR/CD3介导的InsPL水解酶。我们已经能够诱导InsPL
添加非水解物对通透性T细胞的水解作用
GTP的类似物(如GTP GammaS),否则对
完好无损的细胞。GTPGammaS激活一种调节PLC的G蛋白
活性,从而绕过TCR/CD3(或其他细胞表面结构)。
CAMP/PKA通路激活导致InsPL抑制
通过TCR/CD3微扰触发的水解酶,但不影响
GTP-GammaS诱导PLC激活。因此,这两条路径可能是
截然不同。尽管cAMP介导的抑制不会在
通透性,加入纯化的PKA重建了抑制作用
效应,这与特定的磷酸化模式有关
包括一个PLC同工酶PLC-Gamma1。尝试
将使理解PLC之间的功能关系-
通过PKA和CD3介导的激活使Gamma1磷酸化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M A ALAVA其他文献
M A ALAVA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M A ALAVA', 18)}}的其他基金
MODULATION OF T CELL RECEPTOR (TCR) SIGNAL TRANSDUCTION BY CAMP
CAMP 对 T 细胞受体 (TCR) 信号转导的调节
- 批准号:
3811107 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
-- - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
-- - 项目类别:














{{item.name}}会员




